---

****SECURITIES AND EXCHANGE COMMISSION



**FORM10-QSB**









**MedXLink, Corp.**



(State or other jurisdiction of	(IRS Employer

incorporation or organization)	Identification No.)

878 North Main, #124; Layton, UT 84041







Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section
13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter
period that the registrant was required to file such reports) and (2) has been subject to such filing
requirements for the past 90 days.              Yes X	No







---



**ITEM 1 - FINANCIAL STATEMENTS**

The condensed financial statements included herein have been prepared by the Company,
pursuant to the rules and regulations of the Securities and Exchange Commission.

In the opinion of the Company, all adjustments, consisting of only normal recurring
adjustments, necessary to present fairly the financial position of the Company as of December 31,
2004 and the results of its operations and changes in its financial position from September 30, 2004
through December 31, 2004 have been made.  The results of its operations for such interim period
is not necessarily indicative of the results to be expected for the entire year.

---



Balance Sheets

(Unaudited)

|                                                                                                                                                    | December 31,


2004 | September 30,


2004
|--------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------- | --------------------
|**Assets**                                                                                                                                         
|Current Assets                                                                                                                                      |                     |                     
|Cash                                                                                                                                                | $	391               | $	399               
|Total Assets                                                                                                                                        | $	391               | $	399               
|                                                                                                                                                    |                     |                     
|**Liabilities and Stockholders' Equity**                                                                                                           
|Current Liabilities                                                                                                                                 |                     |                     
|Accounts Payable                                                                                                                                    | $	 15,975           | $	15,770            
|Taxes Payable                                                                                                                                       | 3,200               | 3,200               
|Interest Payable                                                                                                                                    | 22,201              | 20,287              
|Notes Payable                                                                                                                                       | 76,538              | 76,538              
|Total Current Liabilities                                                                                                                           | 117,914             | 115,795             
|                                                                                                                                                    |                     |                     
|Stockholders' Equity                                                                                                                                |                     |                     
|Common Stock; 100,000,000 Shares Authorized at $.001
Par Value; 2,892,404 Shares Issued and Outstanding at
December 31, 2004 and September 30, 2004 | 2,892               | 2,892               
|Additional Paid in Capital                                                                                                                          | 322,035             | 322,035             
|Accumulated Deficit                                                                                                                                 | (442,450)           | (440,323)           
|Total Stockholders' Equity (Deficit)                                                                                                                | (117,523)           | (115,396)           
|Total Liabilities and Stockholders' Equity                                                                                                          | $	391               | $	399               

---



**MedXLink, Corp.**

(Unaudited)

|                                    | For the Three Months Ended
|----------------------------------- | --------------------------
|                                    | December 31,


2004       
|Revenue                             | $-                        
|                                    |                           
|Expenses                            |                           
|General & Administrative            | 214                       
|Total Expenses                      | 214                       
|Loss from Operations                | (214)                     
|                                    |                           
|Other Income (Expenses)             |                           
|Interest Expense                    | (1,913)                   
|Total Other Income(Expenses)        | (1,913)                   
|Net Income (Loss)-Before Taxes      | (2,127)                   
|Taxes                               | -                         
|Net Income (Loss)                   | $	(2,127)                 
|                                    |                           
|Loss per Common Share               | $-                        
|Weighted Average Outstanding Shares | 2,892,404                 

---



******MedXLink, Corp.**

Statements of Cash Flows

(Unaudited)

|                                                 | For the Three Months Ended
|------------------------------------------------ | --------------------------
|                                                 | December 31,


2004       
|Cash Flows from Operating Activities             |                           
|Net Income (Loss)                                | $	(2,127)                 
|Adjustments to Reconcile Net (Loss) to Net Cash; |                           
|Non Cash Transactions                            | -                         
|Increase (Decrease) in Interest Payable          | 1,913                     
|Increase (Decrease) in Taxes Payable             | -                         
|Increase (Decrease) in Accounts Payable          | 206                       
|Net Cash Provided (Used) by Operating Activities | (8)                       
|Cash Flows from Investing Activities             |                           
|Net Cash Provided (Used) by Investing Activities | -                         
|Cash Flows from Financing Activities             |                           
|Proceeds from Notes Payable                      | -                         
|Net Cash Provided (Used) by Financing Activities | -                         
|Increase (Decrease) in Cash                      | (8)                       
|Cash, Beginning of Period                        | 399                       
|Cash, End of Period                              | $	391                     
|Supplemental Cash Flow Information               |                           
|Interest                                         | $-                        
|Income Taxes (Including Penalties & Interest)    | -                         
|                                                

---







NOTE 1 - Interim Financial Statements

The financial statements for the three months ended December 31, 2004 were prepared from the books and
records of the company.  Management believes that all adjustments have been made to the financial
statements to make a fair presentation of the financial condition of the company as of December 31, 2004.
The results of the three months are not indicative of a full year of operation for the Company.

Certain information and footnote disclosures normally included in financial statements prepared in
accordance with generally accepted accounting principles, in the United States of America, have been
condensed or omitted.  It is suggested that these financial statements be read in conjunction with the
financial statements and notes thereto included in the Company's September 30, 2004 audited financial
statements.  The results of operations for the period ended December 31, 2004 are not necessarily indicative
of the operating results for the full year.

**ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS.**

Liquidity and Capital Resources.  The Registrant had approximately $(117,523) as operating capital
at December 31, 2004, compared to $(115,396) for the same period last year. The Company intends to raise
additional funds as needed through private placements with accredited and sophisticated investors.

Results of Operation.  Due to the lack of operations during the quarter ended December 31, 2004,
the registrant had a net loss of $(2,127) compared to a net loss of $(2,434) for the same period last year.

Plan of Operations.   The Company is currently in the process of looking for business opportunities
to acquire or merge with.  There is no guarantee that management will be successful in finding such an
opportunity.  During this process, the Company intends to raise operational capital through private
placements.

**ITEM 3 - CONTROLS AND PROCEDURES.**

(a) Evaluation of disclosure controls and procedures.  The Company's principal executive officer and
its principal financial officer, based on their evaluation of the Company's disclosure controls over financial
reporting and procedures (as defined in Exchange Act Rules 13a-14 (c)) as of a date within 90 days prior
to the filing of this Quarterly Report on Form 10-QSB, have concluded that the Company's disclosure
controls over financial reporting  and procedures are adequate and effective for the purposes set forth in the
definition in Exchange Act rules.

---



(b) Changes in internal controls over financial reporting.  There were no significant changes in the
Company's internal controls over financial reporting or in other factors that could significantly affect the
Company's internal controls subsequent to the date of their evaluation.





**OTHER INFORMATION**

Item 1.	Legal Proceedings	None

Item 2.	Changes in Securities	None

Item 3.	Defaults Upon Senior Securities	None

Item 4.	Submission of Matters to a Vote of Security Holders	None

Item 5.	Other Information	None

Item 6.	Exhibits and Reports on Form 8-K

1) Exhibits.

---



31.  Written Statement of Chief Executive Officer and Chief Financial Officer with respect to
compliance with Section 302 of the Sarbanes-Oxley Act of 2002.

32.  Written Statement of Chief Executive Officer and Chief Financial Officer with  respect to
compliance with Section 13(a) or 15(d) of  the Securities Exchange Act of 1934 and pursuant
to 18 U.S.C. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002



2) Reports on Form 8-K.



None.

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned authorized officer.

Dated: January 14, 2005	**MedXLink, Corp.**

/S/ Dean Becker

Dean Becker



---

**Exhibit 31**

**SECTION 302 CERTIFICATION**

I, Dean Becker, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of MedXLink, Corp;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by this quarterly
report.

3.  Based on my knowledge, the financial statements, and other financial information included in this
quarterly report, fairly present in all material respects the financial condition, results of operations and cash
flows of the registrant as of, and for, the periods presented in this quarterly report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in
Exchange Act Rules 12a-15(f) and 15d-15(f))  for the registrant and have:

a) Designed such disclosure controls and procedures or caused such controls and procedures to be designed
under my supervision, to ensure that material information relating to the registrant, including its consolidated
subsidiaries, is made known to me by others within those entities, particularly during the period in which this
quarterly report is being prepared.



b) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented
in this report my conclusions about the effectiveness of the disclosure controls and procedures as of
the end of the period covered by this quarterly report based on such evaluations; and

c) Disclosed in this report any change in the small business issuer's internal control over financial
reporting that occurred during the small business issuer's most recent fiscal quarter that has
materially affected, or is reasonably likely to materially affect, the registrant's internal control over
financial reporting.

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting,
to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing
the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal controls
over financial reporting which could adversely affect the registrant's ability to record, process,
summarize and report financial data and have identified for the registrant's auditors any material
weaknesses in internal controls over financial reporting; and

b) Any fraud, whether or not material, that involves management or other employees who have a
significant role in the registrant's internal controls over financial reporting.

Date: January 14, 2005	/s/Dean Becker

Dean Becker

Chief Executive Officer

and Principle Accounting Officer

---



**Exhibit 32**









In connection with the Quarterly Report of MedXLink, Corp, on Form 10-QSB for the period ending
December 31, 2004 as filed with the Securities and Exchange Commission on the date hereof (the *"Report"*),
the undersigned, Dean Becker, Chief Executive Officer and Principle Accounting Officer  of the Company,
certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13 (a) or 15 (d) of the Securities
Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial
condition and result of operations of the Company.

Date: January 14, 2005	/s/Dean Becker

Dean Becker,

Chief Executive Officer

and Principle Accounting Officer

---